Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Prostate (Late Stage^), 2016-2020

All Races (includes Hispanic), Male, All Ages

Sorted by Percentlate
State
 sort alphabetically by name ascending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Percent of Cases with Late Stage
 sort by percent late ascending
US (SEER+NPCR) 1 23.6 (23.5, 23.7) N/A 44,928 21.1
Vermont 6 31.9 (29.6, 34.4) 1 (1, 8) 146 30.7
Hawaii 3 27.2 (25.7, 28.8) 11 (5, 22) 258 27.2
Washington 5 27.1 (26.4, 27.9) 12 (7, 18) 1,195 26.3
Oregon 6 25.3 (24.4, 26.2) 20 (15, 29) 688 26.2
Minnesota 6 29.6 (28.8, 30.5) 4 (1, 8) 1,017 25.7
California 3 24.1 (23.8, 24.4) 28 (23, 31) 5,168 25.0
Iowa 3 30.1 (29.0, 31.2) 3 (1, 8) 607 25.0
Wisconsin 6 30.4 (29.6, 31.2) 2 (1, 7) 1,147 24.9
Maine 6 24.4 (23.1, 25.9) 25 (15, 35) 250 24.4
North Dakota 6 29.5 (27.3, 32.0) 5 (1, 17) 133 23.8
Colorado 6 24.3 (23.5, 25.1) 27 (18, 32) 753 23.7
Massachusetts 3 27.0 (26.3, 27.7) 15 (8, 19) 1,144 23.5
Missouri 6 22.6 (21.9, 23.3) 33 (30, 38) 878 23.5
Illinois 3 27.1 (26.6, 27.7) 14 (8, 17) 2,036 23.4
Arizona 6 17.5 (16.9, 18.0) 49 (46, 49) 798 22.8
Alaska 6 23.0 (20.7, 25.5) 32 (15, 44) 88 22.4
Pennsylvania 6 24.6 (24.2, 25.1) 24 (19, 29) 2,109 22.4
New Hampshire 6 26.4 (24.9, 27.9) 16 (6, 27) 250 22.3
Nebraska 6 27.5 (26.1, 28.9) 9 (5, 20) 321 22.2
Connecticut 3 27.3 (26.3, 28.3) 10 (6, 18) 623 21.9
District of Columbia 6 29.1 (26.4, 32.0) 6 (1, 21) 89 21.8
Ohio 6 24.9 (24.4, 25.4) 23 (18, 28) 1,863 21.8
Rhode Island 6 25.1 (23.4, 26.9) 22 (9, 34) 171 21.8
Montana 6 29.0 (27.3, 30.8) 7 (1, 16) 221 21.6
South Dakota 6 27.1 (25.1, 29.2) 13 (3, 27) 151 21.6
New Mexico 3 18.4 (17.4, 19.5) 47 (43, 49) 250 21.5
Utah 3 25.4 (24.2, 26.6) 19 (11, 30) 354 21.4
Idaho 3 25.9 (24.5, 27.3) 18 (8, 29) 274 21.3
Michigan 6 23.6 (23.0, 24.1) 30 (25, 34) 1,537 20.9
Louisiana 3 28.3 (27.4, 29.3) 8 (4, 14) 786 20.6
Texas 3 21.0 (20.7, 21.4) 41 (36, 43) 2,992 20.3
Florida 6 19.4 (19.1, 19.7) 44 (43, 46) 2,933 19.9
New York 3 26.1 (25.7, 26.5) 17 (13, 21) 3,057 19.8
Virginia 6 20.7 (20.1, 21.3) 42 (37, 43) 1,032 19.8
Wyoming 6 22.2 (20.1, 24.5) 36 (19, 45) 87 19.3
South Carolina 6 21.4 (20.7, 22.1) 38 (33, 43) 704 19.2
Mississippi 6 25.3 (24.2, 26.4) 21 (13, 30) 447 19.1
North Carolina 6 24.3 (23.8, 24.9) 26 (20, 31) 1,500 19.1
Tennessee 6 22.3 (21.7, 23.0) 35 (31, 39) 930 19.1
Kentucky 3 21.1 (20.3, 21.9) 40 (35, 43) 571 19.0
Oklahoma 6 18.8 (18.0, 19.6) 45 (43, 49) 441 18.8
Kansas 6 21.2 (20.2, 22.2) 39 (33, 43) 373 18.3
Arkansas 6 20.5 (19.6, 21.5) 43 (36, 45) 383 18.2
West Virginia 6 17.9 (16.9, 19.0) 48 (44, 49) 229 17.7
Georgia 3 24.0 (23.4, 24.6) 29 (22, 32) 1,347 17.5
Delaware 6 21.9 (20.3, 23.7) 37 (24, 43) 141 16.9
Maryland 6 22.4 (21.7, 23.2) 34 (30, 39) 792 16.3
New Jersey 3 23.1 (22.5, 23.7) 31 (28, 36) 1,250 16.1
Alabama 6 18.6 (17.9, 19.3) 46 (44, 49) 578 15.7
Puerto Rico 6 13.5 (12.7, 14.2) N/A 272 9.5
Indiana 6
data not available
N/A
data not available
data not available
Nevada 6
data not available
N/A
data not available
data not available
Notes:
Created by statecancerprofiles.cancer.gov on 03/28/2024 12:22 pm.

State Cancer Registries may provide more current or more local data.

Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Indiana, Nevada

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

Data not available for this combination of data selections.

Source: SEER and NPCR data. For more specific information please see the table.
Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top